Suitability is determined by a licensed provider, and individual results vary
Effective Weight Loss: Semaglutide 2.5mg is renowned for its capacity to induce significant and lasting weight loss in individuals grappling with excess body weight
Polysomnography (a sleep study) was conducted on healthy individuals and depressed patients, revealing that SSRIs can lead to decreased sleep efficiency and total sleep time, longer time to fall asleep, and disrupted sleep continuity with more awakenings and wake time during sleep
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S
